Procyanidin A1 Alleviates Inflammatory Response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 Pathways in RAW264.7 cells

• Published in: Scientific reports Vol. 9; no. 1; pp. 15087 - 13
• Main Authors: Han, Shan, Gao, Hongwei, Chen, Shaoru, Wang, Qinqin, Li, Xinxing, Du, Li-Jun, Li, Jun, Luo, Ying-Ying, Li, Jun-Xiu, Zhao, Li-Chun, Feng, Jianfang, Yang, Shilin
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 21.10.2019; Nature Publishing Group; Nature Portfolio
• Subjects: 13/1; 13/21; 13/95; 692/308/153; 692/4017; Animals; Anti-inflammatory agents; Catechin - chemistry; Catechin - pharmacology; Cell Nucleus - drug effects; Cell Nucleus - metabolism; Cytokines - metabolism; Heme Oxygenase-1 - metabolism; Humanities and Social Sciences; Inflammation - pathology; Inflammation Mediators - metabolism; Inflammatory diseases; Interleukin 6; Lipopolysaccharides; MAP kinase; Membrane potential; Membrane Potential, Mitochondrial - drug effects; Mice; Mitochondria; Mitogen-Activated Protein Kinases - metabolism; Models, Biological; Molecular modelling; multidisciplinary; NF-E2-Related Factor 2 - metabolism; NF-kappa B - metabolism; NF-κB protein; Nitric-oxide synthase; Nuclear transport; Oxidative stress; Phosphorylation; Proanthocyanidins - chemistry; Proanthocyanidins - pharmacology; Protein Transport - drug effects; RAW 264.7 Cells; Reactive Oxygen Species - metabolism; Science; Science (multidisciplinary); Signal Transduction; TLR4 protein; Toll-like receptors; Toll-Like Receptors - metabolism; Translocation; Tumor necrosis factor-α
• DOI: 10.1038/s41598-019-51614-x
• ISSN: 2045-2322

Inflammation is a complex physiological process that poses a serious threat to people’s health. However, the potential molecular mechanisms of inflammation are still not clear. Moreover, there is lack of effective anti-inflammatory drugs that meet the clinical requirement. Procyanidin A1 (PCA1) is a monomer component isolated from Procyanidin and shows various pharmacological activities. This study further demonstrated the regulatory role of PCA1 on lipopolysaccharide (LPS)-stimulated inflammatory response and oxidative stress in RAW264.7 cells. Our data showed that PCA1 dramatically attenuated the production of pro-inflammatory cytokines such as NO, iNOS, IL-6, and TNF-α in RAW264.7 cells administrated with LPS. PCA1 blocked IκB-α degradation, inhibited IKKα/β and IκBα phosphorylation, and suppressed nuclear translocation of p65 in RAW264.7 cells induced by LPS. PCA1 also suppressed the phosphorylation of JNK1/2, p38, and ERK1/2 in LPS-stimulated RAW264.7 cells. In addition, PCA1 increased the expression of HO-1, reduced the expression of Keap1, and promoted Nrf2 into the nuclear in LPS-stimulated RAW264.7 cells. Cellular thermal shift assay indicated that PCA1 bond to TLR4. Meanwhile, PCA1 inhibited the production of intracellular ROS and alleviated the depletion of mitochondrial membrane potential in vitro . Collectively, our data indicated that PCA1 exhibited a significant anti-inflammatory effect, suggesting that it is a potential agent for the treatment of inflammatory diseases.